Healthcare and Life Science
SolasCure completes phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel
Aurase Wound Gel shows 22x faster debridement and 7x faster healing compared to standard of care in sloughy venous leg ulcers, supporting advancement to the next phase of developmentData confirms dual mechanism of action, including activation of tissue repair pathways in chronic woundsC...
Why Human Factors Will Drive Business Growth in 2026
When was the last time you abandoned a product because it was frustrating to use? When products are frustrating to use, users will abandon them, share their discontent or fail to adopt them in the first place.For start-ups, that could mean losing customers or a potential investment oppo...
Centauri Therapeutics extends Series A to £30M with £6M investment from AMR Action Fund to support progression of lead clinical candidate
Clinical candidate in ABX-01 programme, CTX-187, currently in development ahead of first in-human clinical trials to target Gram-negative bacterial infectionsInvestment from the world’s largest venture capital fund focused exclusively on antimicrobial therapeutics and diagnostics extend...
Announcing the inaugural Imposter Phenomenon Awareness Day
Dr Kate Atkin and Dr Terri Simpkin are launching the inaugural International Imposter Phenomenon Awareness Day on Friday 27th February. Why phenomenon and not Syndrome? Because words matter and they can give you power to change or take it away. ...
Syndex Bio unveils mcPCR Technology at AGBT 2026 following $15.5M seed financing
• mcPCR enables precise copying of DNA methylation during DNA amplification, overcoming a fundamental limitation of PCR, and unlocks new opportunities for sensitive detection of cancer, chronic disease, and in basic research• Launch follows ...
Loughborough University and Science in Sport (SiS) extend partnership in elite sport and performance nutrition
Loughborough and Blackburn, UK, 23 February 2026: Loughborough University and Science in Sport (SiS) announces a renewed three-year partnership, strengthening the organisations’ long-standing collaboration across elite sport and performance nutrition.The agreement with SiS, the glo...
Before Partnership: Why Qualification Determines Whether Innovation Can Scale
Why early governance readiness determines whether proof can become practice
At last: Sync passkeys across your devices
Be honest, when was the last time you forgot a password and ended up in that endless loop of “reset your password” emails?It’s one of the biggest frustrations of modern working life.It might finally be coming to an end! Microsoft has announced that passkeys can now be synced across your...
Axol Bioscience acquires ophthalmology business from Newcells Biotech
· Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models · Strengthens position as the leading independent provider of physiologically-relevant in vitro retinal models for ophthalmology drug discovery and safety...
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Partnership will deliver AI-guided end-to-end workflow to access challenging membrane protein targetsTo de-risk and shorten path to critical structural and biophysical insights that inform structure-based drug designCambridge, UK, Boston MA, USA and Villigen, Switzerland, 17 February 20...